Stock Appreciation Rights (SARs) are a strategic tool used in Cannabis ESOPs to reward employees with financial upside without granting them actual equity ownership. SARs are not limited to ESOP companies—they can be used by private, public, and non-ESOP firms—but they’re especially useful in cannabis where control and licensing concerns often restrict traditional equity plans.
How Do Stock Appreciation Rights Work?
SARs grant employees the right to receive the increase in the value of company stock over a set period. For example, if the stock is valued at $10 at the time the SARs are granted and the value grows to $18 when exercised, the employee receives the $8 difference—either in cash or stock equivalents, depending on the plan’s design.
Unlike options, SARs typically do not require the employee to purchase stock. There’s no out-of-pocket cost or risk of buying stock in a volatile market. SARs are usually awarded to employees considered critical to the company’s growth, but who aren’t receiving significant benefit from the ESOP itself (such as senior employees with smaller share allocations).
Benefits of SARs for Cannabis Companies
For cannabis business owners, SARs offer a few important advantages:
Employees don’t become shareholders. SARs are a contractual agreement, not stock issuance.
Since SARs aren’t equity, owners can avoid triggering control or licensing issues that might arise from issuing real shares.
SARs can be tied to specific milestones or performance targets.
Employees typically exercise SARs at a liquidity event like a sale, recapitalization, or redemption, receiving cash instead of equity.
Example Scenario of SARs in Action
Let’s say a cannabis company has a valuation of $25 million when SARs are issued. A senior operations executive is granted SARs on 0.5% of the company’s value. Five years later, the company is valued at $40 million. The appreciation on the SARs equals $15 million × 0.5% = $75,000. That executive is entitled to a $75,000 payout, assuming the vesting and trigger conditions are met.
Key Takeaways About SARs in Cannabis ESOPs
- SARs are not actual stock—they’re a right to the value increase.
- They are ideal for cannabis companies where equity issuance is complicated.
- They can be designed to mimic stock-based rewards without regulatory burden.
- They are used as targeted retention and bonus tools for key employees.
- They do not grant voting rights or ownership privileges.
Why Cannabis Companies Use SARs Instead of Options
Traditional stock options are often less attractive in cannabis due to control, licensing, and ownership limitations. SARs solve that problem. They deliver the “economic upside” of equity without the compliance headaches or dilution.
By using SARs alongside an ESOP, cannabis companies can create a balanced and flexible compensation structure that rewards employees while preserving founder control.